141 related articles for article (PubMed ID: 3840949)
61. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
[TBL] [Abstract][Full Text] [Related]
62. Antitumor activity of newly isolated antibiotics, 3-dichloromethylactinobolins.
Okumoto T; Kontani M; Hoshino H; Nakanishi M
J Pharmacobiodyn; 1980 Mar; 3(3):177-82. PubMed ID: 7205539
[TBL] [Abstract][Full Text] [Related]
63. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
Kobayashi E; Okamoto A; Asada M; Okabe M; Nagamura S; Asai A; Saito H; Gomi K; Hirata T
Cancer Res; 1994 May; 54(9):2404-10. PubMed ID: 8162588
[TBL] [Abstract][Full Text] [Related]
64. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.
Moyer JD; Malinowski NM; Treanor SP; Marquez VE
Cancer Res; 1986 Jul; 46(7):3325-9. PubMed ID: 3708566
[TBL] [Abstract][Full Text] [Related]
65. The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Jackman AL; Newell DR; Gibson W; Jodrell DI; Taylor GA; Bishop JA; Hughes LR; Calvert AH
Biochem Pharmacol; 1991 Oct; 42(10):1885-95. PubMed ID: 1741766
[TBL] [Abstract][Full Text] [Related]
66. Biological effects of acetomycin. I. Activity against tumor cells in vitro and in vivo.
Mamber SW; Mitulski JD; Hamelehle KL; French JC; Hokanson GC; Shillis JL; Leopold WR; Von Hoff DD; Tunac JB
J Antibiot (Tokyo); 1987 Jan; 40(1):73-6. PubMed ID: 3558118
[TBL] [Abstract][Full Text] [Related]
67. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
68. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
Bissery MC; Vrignaud P; Lavelle F; Chabot GG
Anticancer Drugs; 1996 Jun; 7(4):437-60. PubMed ID: 8826613
[TBL] [Abstract][Full Text] [Related]
69. Biological activity of macromomycin.
Hidaka T; Yano Y; Yamashita T; Watanabe K
J Antibiot (Tokyo); 1979 Apr; 32(4):340-6. PubMed ID: 468721
[TBL] [Abstract][Full Text] [Related]
70. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Holm B; Jensen PB; Sehested M
Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
[TBL] [Abstract][Full Text] [Related]
71. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
72. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
73. In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models.
Zylicz Z; Wagener DJ; van Rennes H; van der Kleijn E; Lelieveld P; van den Broek LA; Ottenheijm HC
Invest New Drugs; 1988 Dec; 6(4):285-92. PubMed ID: 3229941
[TBL] [Abstract][Full Text] [Related]
74. Mechanisms of action of a novel macromolecular antitumor antibiotic, SN-07, on mouse leukemia L1210 cells in culture.
Yajima N; Miyata N; Kawanishi G; Katayama S; Tsukagoshi S
Jpn J Cancer Res; 1987 Oct; 78(10):1121-7. PubMed ID: 3119545
[TBL] [Abstract][Full Text] [Related]
75. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
Drori S; Sprecher H; Shemer G; Jansen G; Goldman ID; Assaraf YG
Eur J Biochem; 2000 Feb; 267(3):690-702. PubMed ID: 10651805
[TBL] [Abstract][Full Text] [Related]
76. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
[TBL] [Abstract][Full Text] [Related]
77. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
[TBL] [Abstract][Full Text] [Related]
78. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
[TBL] [Abstract][Full Text] [Related]
79. Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells.
Hall IH; Hall ES; Chi LK; Shaw BR; Sood A; Spielvogel BF
Anticancer Res; 1992; 12(4):1091-7. PubMed ID: 1503401
[TBL] [Abstract][Full Text] [Related]
80. Sultriecin, a new antifungal and antitumor antibiotic from Streptomyces roseiscleroticus. Production, isolation, structure and biological activity.
Ohkuma H; Naruse N; Nishiyama Y; Tsuno T; Hoshino Y; Sawada Y; Konishi M; Oki T
J Antibiot (Tokyo); 1992 Aug; 45(8):1239-49. PubMed ID: 1399844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
